Kirsi Ketola

2.4k total citations
27 papers, 1.4k citations indexed

About

Kirsi Ketola is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kirsi Ketola has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Kirsi Ketola's work include Prostate Cancer Treatment and Research (14 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Kirsi Ketola is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Kirsi Ketola collaborates with scholars based in Finland, Canada and United States. Kirsi Ketola's co-authors include Kristiina Iljin, Olli Kallioniemi, Vidal Fey, Paula Vainio, Jennifer L. Bishop, Amina Zoubeidi, Alastair Davies, Pekka Kohonen, Merja Perälä and Ka Mun Nip and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Kirsi Ketola

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirsi Ketola Finland 17 736 424 315 311 109 27 1.4k
Xing Zhou China 21 959 1.3× 174 0.4× 314 1.0× 327 1.1× 113 1.0× 69 1.6k
Ting‐Yu Lin Taiwan 21 686 0.9× 141 0.3× 299 0.9× 133 0.4× 49 0.4× 66 1.4k
Pei‐Ling Hsu United States 27 742 1.0× 194 0.5× 385 1.2× 170 0.5× 70 0.6× 78 2.1k
Kathleen A. O’Leary United States 21 686 0.9× 91 0.2× 645 2.0× 212 0.7× 90 0.8× 40 1.5k
David A. Potter United States 25 1.2k 1.7× 447 1.1× 622 2.0× 249 0.8× 570 5.2× 63 2.5k
Esther P. Black United States 18 422 0.6× 135 0.3× 260 0.8× 140 0.5× 42 0.4× 38 889
Dung‐Tsa Chen United States 28 1.3k 1.7× 416 1.0× 1.2k 3.7× 684 2.2× 54 0.5× 106 2.9k
Joo Sang Lee South Korea 23 1.0k 1.4× 338 0.8× 762 2.4× 452 1.5× 133 1.2× 64 2.3k
Ning Jin China 19 636 0.9× 174 0.4× 645 2.0× 175 0.6× 36 0.3× 66 1.4k
Mahadeo A. Sukhai Canada 22 700 1.0× 139 0.3× 450 1.4× 395 1.3× 52 0.5× 66 1.5k

Countries citing papers authored by Kirsi Ketola

Since Specialization
Citations

This map shows the geographic impact of Kirsi Ketola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsi Ketola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsi Ketola more than expected).

Fields of papers citing papers by Kirsi Ketola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirsi Ketola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsi Ketola. The network helps show where Kirsi Ketola may publish in the future.

Co-authorship network of co-authors of Kirsi Ketola

This figure shows the co-authorship network connecting the top 25 collaborators of Kirsi Ketola. A scholar is included among the top collaborators of Kirsi Ketola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirsi Ketola. Kirsi Ketola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaljunen, Heidi, Lucia Nappi, Ladan Fazli, et al.. (2024). DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2. Communications Biology. 7(1). 108–108. 8 indexed citations
2.
Kaljunen, Heidi, Petri I. Mäkinen, Seppo Ylä‐Herttuala, et al.. (2024). SIX2 promotes cell plasticity via Wnt/β-catenin signalling in androgen receptor independent prostate cancer. Nucleic Acids Research. 52(10). 5610–5623. 11 indexed citations
3.
Kaljunen, Heidi, Sinja Taavitsainen, Ville Paakinaho, et al.. (2023). Fanconi anemia pathway regulation by FANCI in prostate cancer. Frontiers in Oncology. 13. 1260826–1260826. 3 indexed citations
4.
Takabe, Piia, Sami Heikkinen, Niina Aaltonen, et al.. (2022). M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR–NF-κB Signaling. Journal of Investigative Dermatology. 142(11). 3041–3051.e10. 20 indexed citations
5.
Ketola, Kirsi, Heidi Kaljunen, Sinja Taavitsainen, et al.. (2021). Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Research. 81(19). 4901–4909. 8 indexed citations
6.
Tamarov, Konstantin, Maria‐Viola Martikainen, Kirsi Ketola, et al.. (2020). Thermal dose as a universal tool to evaluate nanoparticle-induced photothermal therapy. International Journal of Pharmaceutics. 587. 119657–119657. 16 indexed citations
7.
Malinen, Marjo, et al.. (2020). BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation. Oncogene. 39(11). 2391–2407. 13 indexed citations
8.
Ramberg, Håkon, Helene Hartvedt Grytli, Alfonso Urbanucci, et al.. (2019). The β2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells. Molecular Cancer Research. 17(11). 2154–2168. 18 indexed citations
9.
Jauhiainen, Suvi, Johanna P. Laakkonen, Kirsi Ketola, et al.. (2019). Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function. Frontiers in Physiology. 10. 224–224. 19 indexed citations
10.
Felszeghy, Szabolcs, Sanna Pasonen‐Seppänen, Ali Koskela, et al.. (2019). Using online game-based platforms to improve student performance and engagement in histology teaching. BMC Medical Education. 19(1). 273–273. 161 indexed citations
11.
Ketola, Kirsi, et al.. (2017). Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition. Clinical Cancer Research. 23(22). 6923–6933. 31 indexed citations
12.
Thaper, Daksh, Sepideh Vahid, Ka Mun Nip, et al.. (2017). Targeting Lyn regulates Snail family shuttling and inhibits metastasis. Oncogene. 36(28). 3964–3975. 30 indexed citations
13.
Bishop, Jennifer L., Daksh Thaper, Sepideh Vahid, et al.. (2016). The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer. Cancer Discovery. 7(1). 54–71. 263 indexed citations
14.
Ketola, Kirsi, Miro Viitala, Pekka Kohonen, et al.. (2016). High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.. PubMed. 5(1). 12–22. 15 indexed citations
15.
Bishop, Jennifer L., Alastair Davies, Kirsi Ketola, & Amina Zoubeidi. (2015). Regulation of tumor cell plasticity by the androgen receptor in prostate cancer. Endocrine Related Cancer. 22(3). R165–R182. 43 indexed citations
16.
Ketola, Kirsi, Mika Hilvo, Tuulia Hyötyläinen, et al.. (2012). Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. British Journal of Cancer. 106(1). 99–106. 135 indexed citations
17.
Ketola, Kirsi, Olli Kallioniemi, & Kristiina Iljin. (2012). Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells. PLoS ONE. 7(12). e51470–e51470. 23 indexed citations
18.
Vainio, Paula, Santosh Gupta, Kirsi Ketola, et al.. (2011). Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer. American Journal Of Pathology. 178(2). 525–536. 92 indexed citations
19.
Iljin, Kristiina, Kirsi Ketola, Paula Vainio, et al.. (2009). High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth. Clinical Cancer Research. 15(19). 6070–6078. 180 indexed citations
20.
Puustinen, Pietri, Melissa R. Junttila, Sari Vanhatupa, et al.. (2009). PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A–Mediated Inactivation in Human Malignant Glioma. Cancer Research. 69(7). 2870–2877. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xing Zhou Breakdown of academic impact, for papers by Ting‐Yu Lin Breakdown of academic impact, for papers by Pei‐Ling Hsu Breakdown of academic impact, for papers by Kathleen A. O’Leary Breakdown of academic impact, for papers by David A. Potter Breakdown of academic impact, for papers by Esther P. Black Breakdown of academic impact, for papers by Dung‐Tsa Chen Breakdown of academic impact, for papers by Joo Sang Lee Breakdown of academic impact, for papers by Ning Jin Breakdown of academic impact, for papers by Mahadeo A. Sukhai
Rankless by CCL
2026